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Candida albicans is a fungal microorganism commonly found on the normal flora of the human 
body and the environment. An opportunistic pathogen causing local and systemic infection, this 
fungus is one of the leading causes of nosocomial infections through contamination of inserted 
medical devices. More alarming is Candida’s growing multi drug resistance against an already 
limited antifungals for treatment of infections. Alcaligenes faecalis is a bacterium found in the 
soil and is a part of the normal flora of humans, but rarely causes disease. Currently, there is very 
little known about how microbes interact and there is increased interest in how we can exploit 
microbial relationships to better human health. The present study focused on the polymicrobial 
interactions between C. albicans and Alcaligenes faecalis. Previous research from our laboratory 
has shown that A. faecalis exerts an inhibitory effect on C. albicans. While considerable data 
suggests this inhibitory effect is significant in planktonic cultures, there is nothing known about 
how these interactions would work in biofilm growth. Therefore, we examined the interactions 
of Alcaligenes and Candida by attempting to inhibit Candida biofilm growth with Alcaligenes. 
This study may provide information on potential novel therapeutic methods and targets against 
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Candida albicans is an elliptical, dimorphic fungal species that commonly populates the 
mucous membranes of the intestinal tract, vaginal, and oral cavity of the human (and 
mammalians in general) body. The word “candida” has Latin origin from the word “candidus”, 
which means white and “albicans” derived from the Latin word “albico”, meaning to become 
white (1). It is a catalase-positive, opportunistic pathogen, and is known to cause mild to severe 
yeast infections called Candidiasis in people who are immunocompromised.  
Polymorphic Properties 
A defining characteristic of this microorganism (and other yeast species) is its 
polymorphic property. C albicans can transitionally express itself as yeast cells, psuedohyphaes, 
true hyphaes, or chlamydaspores, depending on the environmental/host conditions present (2). 
Under normal conditions (room temperature, anaerobic, pH lower than 6), its phenotype is the 
unicellular, elliptical yeast cell formed by asexual reproduction, or budding. These cells typically 
have diameters of 10-12 micrometers. Upon stimulation of a variety of environmental changes 
(such as temperatures of 37⁰C, pH of 7, production of human serum and CO2/O2), C. albicans 
takes on a multicellular hyphal phenotype, forming mycelial growth (continuous cell replication 
without budding) (5). The pseudohyphal state occurs when a pinching ensues in a yeast cell, 
giving the appearance of a hyphae. Clamydospores can form in extreme and harsh conditions, 
such as during starvation. C albicans can readily switch/reverse between these phenotypes in 
order to increase its chance of growth and proliferation (3). C albicans ability to switch between 
its polymorphic phenotypes provides a great advantage in terms of its survival, pathogenicity, 





Another major virulence factor of C. albicans is its ability to form biofilms. Biofilms are 
groups of cells that are surrounded by a slimy, extracellular matrix that adheres to surfaces. A 
common example is the dental plaque biofilm layer formed by microorganisms that reside in the 
mouth (4). C. albicans can adhere to the surfaces of living and nonliving things, increasing its 
pathogenicity. Biofilm formation begins with the development of the basal layer. This layer 
adheres to the surface of an object or mucous membranes and is made up of joined yeast cells. 
The next phase in this process is the division and multiplication of the hyphal cells (4). Hyphal 
cells are extremely important components of biofilms because they provide organized structural 
support systems for the various cell types that make up this biofilm.  
The cells are surrounded by an extracellular matrix made of glycoproteins, 
polysaccharides (glucose, mannose, rhamnose), lipids, and nucleic acids. Along with 
components created by the cells, the biofilm can incorporate molecules from host cells and the 
environment. These include neutrophils, erythrocytes, and epithelial cells from host cells and C. 
albicans cells that have lysed (13). Research suggests that along with protecting the biofilm from 
the host, extracellular matrix has digestive properties that breakdown and bring in nutrients to 
support the biofilm growth and sustenance. Cells that make up biofilms can also be individually 
spread to other areas of the host (4). These are typically the yeast form of C albicans and are 
likely to form more biofilms once they adhere to a surface. This perpetuates in a repeating cycle 
of biofilm growth and dispersion that can be harmful, even deadly, to the host.  
Biofilms also play a role in virulence as they are able to resist the host immune response 
(6). The presence of high biofilm numbers initiates the innate immune response of the host 
organism; these include release of neutrophils, macrophages, dendritic cells, and epithelial cells. 
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In addition, cell receptors such as Toll-like receptors and lectin receptors can recognize and bind 
to sugars in the biofilm and initiate a signaling cascade response that attracts phagocytic cells to 
the area. The result can be engulfment and destruction of the fungal cells. Research suggests that 
C. albicans has properties that allow it to bypass and escape from this host immune response.  
One way this can occur is through preventing neutrophil activation; a molecule called 
glucans, which is present in the extracellular matrix of C. albicans has the ability to inhibit the 
immune activation by neutrophils. Although these immune cells recognize and surround the 
fungus, they cannot directly cause any damage (4). In addition, the hyphal form of C. albicans 
can escape phagocytic cells even after engulfment by breaking though the membrane of the 
phagocytic cell. Additional research indicates that proteins in C. albicans have the ability to 
block signal cascade pathways, antimicrobial proteins, leukocytes, and other immune cells. 
Infection/Disease 
Controlling and regulating the growth of C albicans is of high interest to researchers due 
to the increasing levels of infections in clinical and nonclinical practices. Candidiasis is a mild to 
severe infection caused by the fungus. Serious forms of candidiasis (like invasive candidiasis) 
can be caused by surgery, antibiotics and immunosuppressive drugs, and burns (7). Many forms 
of this disease can be caused by intake of various antibiotics, which results in the destruction of 
the surrounding commensal bacteria, which would normally work to regulate overgrowth of C. 
albicans. 
The infection in the mouth, throat, and esophageal areas is called thrush, or 
oropharyngeal candidiasis. This is more common in babies under the age of one, and those with 
diabetes, dentures, cancer, or take medications that alter the environment of the oral and 
pharyngeal cavities. The characteristics of this form are white patches on the tongue, mouth, and 
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throat, swelling, diminished sense of taste, soreness/redness, and dry skin and lips. Currently the 
treatments include antifungals like clotrimazole, miconazole, nystatin, and for severe cases, 
fluconazole (8). 
In women, the form of infection in the vagina is vaginal candidiasis (commonly yeast 
infection). Candida albicans causes the second most number of cases of infections of the vagina 
after bacterial species; the number of hospital visits due to vaginal candidiasis is estimated to be 
about 1.4 million (9). This infection can occur as a result of unhygienic practices, consumption 
of hormonal contraceptives, diabetes, or compromised immune system. The symptoms include 
itchy, red, and sore areas in an around the vagina, pain during urination and sexual intercourse, 
and unusual discharge (9). Treatment is through antifungal medicine and include fluconazole, 
through ingestion or direct application on the infected area(s). 
Along with this superficial infections, systemic infection can also occur when the fungus 
enters the blood or internal organs and can cause organ failure and death (11). “C. albicans is a 
leading cause of hospital-acquired infections, it accounts for 15% of all sepsis cases, and is the 
cause of 40% of bloodstream infections in clinical settings” (12). The fungus can colonize many 
medical devices such as catheters, implants, and prosthetics. This is way for the C. albicans to 
potentially enter sensitive areas in the body and blood and can lead to systemic infection and 
irreversible tissue damage (10).  
Due to C. albicans’s resistance to many antifungal medications and host immune 
responses, and its prevalence in clinical infections, it is of high interest to researchers to devise 






 Alcaligenes faecalis, classified as a member of the Alcaligenaceae family, is known to be 
an aerobic, rod bacterium, motile by peritrichous flagella. It was named “faecalis” after its first 
discovery in feces (14). It is a Gram-negative bacterium, containing a cell wall consisting of a 
single layer of peptidoglycan surrounded by an outer membrane made of lipopolysaccharides, 
phospholipids, and surface proteins. It is further characterized as a strictly aerobic microbe which 
grows optimally at temperatures between 20-37 °C and tests positive for both the catalase and 
oxidase tests (15). 
A. faecalis naturally resides in soil and water, as well as in the human gastrointestinal 
commensals, and rarely causes systematic infections. It can, however, in rare incidents, induce 
infections in individuals and animals that have an immunosuppressed immune system, making A. 
faecalis, an opportunistic bacterium in certain situations (16). Some of the infections it can 
induce are peritonitis, meningitis, appendicitis, endocarditis, hepatitis, among others.   
 Like other Gram-negative bacterium, A. faecalis has been known to be highly resistant to 
many classes of antibiotic medications and agents (17). Some of the antibiotics this bacterium is 
resistant to are tetracycline, chloramphenicol, aminoglycosides, polymyxin, streptomycin and 
many others. This resistance can be a factor in explaining why eradication of A. faecalis in 
infected individuals and animals can be especially difficult (18).  
Current Project 
This research project was conducted to test the effect on A. faecalis on C. albicans 
biofilm growth. Previous work in our laboratory has shown that Alcaligenes exerts a strong 
inhibitory effect on Candida growth in planktonic cultures. This inhibition is through a currently 
unknown physical mechanism where Alcaligenes cells must be present to inhibit the Candida 
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cells. As a commensal microorganism of the gastrointestinal tract, A. faecalis may play a role in 
preventing the overgrowth of C. albicans, potentially interfering with the formation of biofilms. 
We therefore wanted to focus our research on three main objectives: 1) can we create Candida 
biofilms in a laboratory environment; 2) does Alcaligenes induce an inhibitory effect on Candida 
biofilms as it does on planktonic Candida cultures; 3) what are the characteristics of the 
interactions between Alcaligenes and Candida. Understanding the interaction between these 
microorganisms may provide new therapeutic targets for treating both planktonic and biofilm 
growth inhibition of C. albicans. 
Methods 
Microorganisms and culture conditions. C. albicans SC5314 (clinical strain), C. albicans 
(ATCC#10295, a laboratory strain), C. albicans yeast-locked, and C. albicans hyphae-locked 
were routinely grown on Yeast Peptone Dextrose (YPD) agar and broth at 37⁰C. The yeast-
locked and hyphae locked Candida strains have a mutation that inhibits them from transitioning 
to their different morphologies and locks them into the single morphology. A. faecalis 
(ATCC#8750) was routinely grown on Luria Bertani (LB) agar and broth at 37⁰C. For co-culture 
experiments, Candida and Alcaligenes were grown in Brain Heart Infusion (BHI) broth. When 
needed, YPD agar plates supplemented with 50µg/ml of Kanamycin were used to inhibit 
Alcaligenes growth while allowing Candida to grow.  
Effect of Heat Killed, cell free supernatant, and wild type spot test on different forms of CA 
Candida strains (yeast-locked, hyphae-locked, clinical strain, laboratory strain) were inoculated 
into YPD broth tubes, incubated at 37⁰C for 24 hours, and used to make microbial lawns on BHI 
agar plates. A. faecalis was inoculated into LB broth, incubated at 37⁰C for 24 hours, and 1mL 
was added to four microcentrifuge tubes. One tube was centrifuged for 5 minutes at 10,000rpm, 
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the resulting supernatant was passed through a 0.22µm filter, and 20µl spotted onto the Candida 
lawns. The second tube was placed in 70⁰C water bath for 10 minutes and 20µl spotted onto the 
Candida lawns. The third tube contained the overnight culture and 20µl was spotted onto the 
Candida lawns. The Candida plates were incubated at 37⁰C for 24 hours and observed for zones 
of inhibition (ZOI) 
 
Microscope Observation of Candida Biofilms C. albicans (laboratory strain) and A. faecalis 
were inoculated into broth media and incubated at 37℃ for 24 hours to use as seed cultures for 
biofilm growth. Coverslips were place in the bottom wells of a 6-well cell culture plate, To use a 
consistent amount of cells for inoculation into the 6-well plate, the OD600 value was found using 
a spectrophotometer, with Candida wells being inoculated at an OD600 = 0.01 (~1x106 cells/ml) 
and Alcaligenes wells being inoculated at an OD600= 0.1 (~1x108 cells/ml) into BHI broth. In a 
6-well plate the following combinations were made: Well 1 (control) = Candida only; Well 2 = 
Candida + Alcaligenes; Well 3 = Candida; Well 4 = Candida + Alcaligenes; Well 5 = Candida; 
Well 6 = Candida + Alcaligenes. This plate was incubated for 24 hours at 37℃, coverslips 
washed with PBS, fixed to a microscope slide, Gram stained, and observed under a 100X 
objective with a Zeiss light microscope. 
 
Quantitation of biofilm formation. C. albicans (laboratory strain) and A. faecalis were 
inoculated into broth media and incubated at 37℃ for 24 hours to use as seed cultures for biofilm 
growth. Coverslips were place in the bottom wells of a 6-well cell culture plate, To use a 
consistent amount of cells for inoculation into the 6-well plate, the OD600 value was found using 
a spectrophotometer, with Candida wells being inoculated at an OD600 = 0.01 (~1x106 cells/ml) 
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and Alcaligenes wells being inoculated at an OD600= 0.1 (~1x108 cells/ml). In a 6-well plate the 
following combinations were made: Well 1 (control) = Candida only; Well 2 = Candida + 
Alcaligenes (1x); Well 3 = Candida + Alcaligenes (2x); Well 4 = Candida + Alcaligenes (3x). 
To increase the concentration of Alcaligenes, cultures were centrifuged to pellet cells, the liquid 
portion removed, and cells were resuspended in a decreased volume of PBS, but the same 
volume added to the appropriate well. This plate was incubated for 24 hours at 37℃. After 
incubation, wells were carefully washed with PBS to remove non-adherent cells, meticulously 
scraped with a pipet tip to dislodge the biofilm from the sides/bottoms of the well and added to a 
microcentrifuge tube. The tube was serially diluted and plated onto YPD agar plates containing 
50µg/ml Kanamycin. These plates were incubated for 24 hours at 37℃ and colony forming units 
(CFU) were enumerated.  
 
Transposon Mutagenesis of A. faecalis and screening for loss-of-function mutants. To create 
random transposon insertion mutants of A. faecalis, we utilized bacterial conjugation with E. coli 
containing pRL27. The plasmid pRL27 is a pir-dependent Tn5 transposon system that contains a 
hyperactive transposase and Kanamycin resistance gene. To induce conjugation, a variety of 
conditions were tested. The first attempt, involved adding both A. faecalis and E. coli pRL27 to 
LB broth, incubating the tube at 37⁰C, with shaking, for 24 hours. Aliquots were plated onto LB 
agar containing Kanamycin & Ampicillin and incubated for 24 hours at 37⁰C and monitored for 
positive clones. Another method involved spotting both A. faecalis and E. coli pRL27 onto LB 
agar plates and incubating them for 24 hours at 37⁰C. The resulting co-colonies that grew were 
meticulously scraped, added to fresh LB broth, serially diluted, plated onto LB agar containing 
Kanamycin & Ampicillin and incubated for 24 hours at 37⁰C and monitored for positive clones. 
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From either method, positive clones were re-screened on Kanamycin & Ampicillin, then 
screened for loss-of-function on Candida lawns spread on LB agar plates. Those that were 
identified as not having the ZOI associated with their interaction with Candida were further 
examined genetically. 
Mutant Genomic DNA Purification and confirmation of transposon insertion. Potential 
mutant Alcaligenes with the Tn5 transposon and wild-type Alcaligenes genomic DNA was 
purified using the Wizard Genomic DNA Purification Kit. The purity of this DNA was measured 
with a nanodrop spectrophotometer. Using primers directed toward the Tn5, polymerase chain 
reaction (PCR) was performed and visualized on a 1% agarose gel stained with Ethidium 
Bromide. 
Results and Discussion 
Analysis of A. faecalis inhibition on different strains of C. albicans. 
Previous work in our laboratory has shown that A. faecalis induces a strong inhibitory effect on 
C. albicans in planktonic cultures. We therefore wanted to examine this interaction in a static 
biofilm form of growth. To confirm that this was a physical interaction, rather than a secreted 
molecule. A. faecalis cells, heat-killed A. faecalis cells, and cell-free A. faecalis supernatant were 
spotted on a variety of Candida strains grown as lawns on agar plates. A laboratory strain of 
Candida and clinical strain of Candida were used to determine if this inhibition was consistent 
among Candida strains. Additionally, Candida is dimorphic in morphology, existing 
transitionally between both a yeast phase and a hyphae phase of growth. Thus, we also used 
Candida strains that have been mutated to remain in either the yeast form (yeast-locked) or 
hyphae form (hyphal-locked) to determine if the morphological state of Candida plays a role in 
A. faecalis inhibition. When examining the Candida clinical and laboratory strains, there were 
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robust ZOI around the A. faecalis cells spotted onto the C. albicans clinical (Figure 1A) and the 
C. albicans laboratory (Figure 1B) strains. The heat-killed A. faecalis cells and the cell-free A. 
faecalis supernatant produced no ZOI for the C. albicans clinical (Figure 1E) and the C. albicans 
laboratory (Figure 1F) strains. When examining the morphology-locked Candida lawns, we 
found the same observations with ZOI around only the A. faecalis cells of yeast (Figure 1C) and 
hyphae-locked (Figure 1D), but not the heat-killed or cell free supernatant of A. faecalis on yeast 
(Figure 1G) or hyphae-locked (Figure1H) Candida lawns. This indicates that the inhibition A. 
faecalis exerts upon C. albicans is through physical contact between the cells. Also, the larger 
ZOI around the yeast and hyphae-locked C. albicans indicates that Candida locked into either 
form makes the fungi more susceptible to this inhibition.  
 
Figure 1: Zones of Inhibitions due to inhibition of Candida by A. faecalis. Observed zones of 
inhibition by AF onto lawns of (A) CA clinical (B) CA lab (C) CA yeast (D) CA hyphae and observed 
zones of inhibition by heat-killed AF and cell free AF supernatant onto lawns of (E) CA clinical (F) CA 
lab (G) CA yeast (H) CA hyphae 
 Inhibition by A. faecalis on Candida biofilms during the attachment phase. 
Upon observing the inhibition of A. faecalis towards C. albicans on agar plates, we wanted to 
examine if this inhibition could also be observed in a much more complex biofilm form of 
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growth. Biofilms have several defined stages of growth with attachment being one of the earliest 
stages. By using 6-well cell culture plates, we inoculated either monocultures of Candida 
(control) or co-cultures of Candida with increasing amounts of A. faecalis, grown for 24 hours, 
and quantitated for the amount of Candida present by assessing colony forming units (CFUs). 
The laboratory strain of Candida had marked decrease in CFUs across the three concentrations 
of A. faecalis cells used (Figure 2). However, the decrease in Candida CFUs did not have a 
larger decrease as the number of A. faecalis cells increased. The inhibitory effect was equal 




Figure 2: Concentration dependent inhibition of C. albicans (laboratory strain) biofilms by A. 
faecalis. Increases in the cell density of A. faecalis added to C. albicans biofilms at the attachment phase 
decrease the amount of Candida CFUs (Top) Representative photos of CFUs from serial dilutions of 
Candida biofilms (Bottom). 
Taking the observations from the laboratory strain of Candida, we wanted to see how a clinical 







C.albicans C. albicans + 1X
A.faecalis
C. albicans + 2X
A.faecalis









Concentration of A. faecalis cells
Candida Biofilm Growth: Lab Strain (CFU)
16 
 
strains of Candida because laboratory strains of microorganisms are rarely challenged which 
produces changes in the microorganism such as a reduction of virulence and reduction 
characteristics typically found in that microbe. On the other hand, clinical strains are challenged 
in the human body as they must combat the human body, antimicrobial treatments, and exposure 
to other microbes. Thus, clinical strains can have changes not only to their natural characteristics, 
but also changes at a genetic level. The clinical strain of Candida reinforced the observations 
found with the laboratory Candida strain and had decreases in CFUs across the three 
concentrations of A. faecalis cells used (Figure 3). Again, the decrease in Candida CFUs did not 
have a larger decrease as the number of A. faecalis cells increased and the inhibitory effect was 




Figure 3: Concentration dependent inhibition of C. albicans (clinical strain) biofilms by A. faecalis. 
Increases in the cell density of A. faecalis added to C. albicans biofilms at the attachment phase decrease 
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The inhibition of both the laboratory and clinical strains of Candida indicate that A. faecalis does 
so ubiquitously among Candida strains. However, a unique and important virulence factor of 
Candida is the ability to change its morphology from a budding yeast, used for attachment and 
dispersion, to a filamentous hypha, used for penetrating and destruction of tissue. We therefor 
wanted to see if the inhibitory action of A. faecalis was evident on the attachment of the yeast-
locked Candida strain which is the morphological form used for the early attachment phase of 
biofilm development. There is a concentration dependent inhibition of yeast-locked Candida by 
A. faecalis, but it required a higher concentration of A. faecalis to see the same inhibitory effects 
that we observed in the clinical and laboratory strains of Candida (Figure 4). This could be due 
to previous data in our laboratory that the yeast form of Candida is more of a “protected 
morphology” when compared to the hyphae form. Typically, different proteins are expressed in 
the hyphae form and the fungi is more susceptible to attack by other microbes, such as 
Pseudomonas. It could be a higher concentration of A. faecalis is needed to exert this inhibitory 
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Figure 4: Concentration dependent inhibition of C. albicans (yeast locked) biofilms by A. faecalis. 
Increases in the cell density of A. faecalis added to C. albicans biofilms at the attachment phase decrease 
the amount of Candida CFUs (Top) Representative photos of CFUs from serial dilutions of Candida 
biofilms (Bottom). 
 
Microscopic analysis of A. faecalis inhibition of C. albicans biofilm attachment. 
The quantitative data obtained from the biofilm experiments gave us a good idea of the amount 
of inhibition A. faecalis has on the early stages of Candida biofilms. However, we wanted to 
visualize any of the phenotypic and morphological changes that may be occurring in the 
attachment phases. To this end, we added coverslips to the bottoms of 6-well cell culture plates 
and inoculated the wells as either monoculture (Candida alone or Alcaligenes alone) or as co-
cultures. These coverslips then were Gram stained and observed for phenotypic differences. In 
this staining, Candida appear Gram-positive and Alcaligenes appear Gram-negative. As shown 
in Figure 5, Candida monocultures demonstrate an ability to attach to and create biofilms on 
coverslips (figure 5A & 5B). These biofilms have both yeast and hyphal morphologies, with 
extensive branching of the hyphae at this stage. Alcaligenes monoculture (figure 5c & 5D) also 
demonstrate an ability to attach to and create biofilms on coverslips. In the co-culture of Candida 
with Alcaligenes, we see fewer Candida cells (figure 5E & 5F). The Candida biofilms have 
limited, shorter hyphae that is not extensively branching. Most of the Candida cells appear to be 
in the yeast morphology. Alcaligenes appear to be clustered around the Candida cells in a 




Figure 5: Inhibition of C. albicans biofilms by A. faecalis. Representative photos of monocultures of 
Candida (A, B), monocultures of Alcaligenes (C, D) or Co-cultures of Candida with Alcaligenes (E, F) 
grown on coverslips.  
 
Random transposon mutagenesis of A. faecalis. 
The genetic elements that are responsible for the inhibitory effects of A. faecalis on C. albicans 
are, as of yet, unknown. To determine the possible genetic factors and pathways associated with 
this inhibition we utilized bacterial conjugation with E. coli containing the pRL27 plasmid to 
transfer a Tn5 transposon into the genome of A. faecalis. This insertion is random but can be 
identified by the transfer of the Kanamycin resistance gene with the transposon. Upon 
conjugation, cells are plated onto LB agar plates containing Kanamycin and Ampicillin. The 
Kanamycin will eliminate any of the A. faecalis that did not take up and incorporate the Tn5 
transposon while Ampicillin will eliminate any of the E. coli in the culture. Positive potential A. 
faecalis mutants were confirmed again on LB Kanamycin/Ampicillin plates and then screened on 
C. albicans lawns. As seen in figure 6, a wild-type A. faecalis is placed on the lawn as a control, 
and potential mutants are patched onto the plate. The loss of function phenotype indicates that 
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the Tn5 transposon inserted into the genome somewhere vital, genetically, to the inhibition of A. 
faecalis. The genomes of these mutants were isolated, and PCR amplified, using primers directed 
toward the transposon, to verify the insert. Unfortunately, the potential mutants we generated 




Figure 6: Generation of A. faecalis random transposon mutants. Potentially positive A. faecalis 
transposon mutants screened for loss of function on lawns of C. albicans.  
 
Conclusion 
This project focused on C. albicans growth inhibition with the bacteria A. faecalis. The 
growth control of C. albicans is of increased interest to researchers as well as clinicians due to 
the highly destructive nature of this nosocomial microorganism. C. albicans is one of the leading 
causes of death by blood infection in hospital settings as a result of contamination on surgical 
devices, catheters, and other objects. Additionally, the fungus can commonly cause various 
forms of candidiasis in humans and is becoming highly drug resistant. An essential virulence 
factor of C. albicans is biofilm growth. This property allows this fungal infection to attach, 
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persist, and rapidly spread to many parts of the body. In this study, the bacteria A. faecalis, 
through a form of physically dependent action, has shown significant inhibition of C. albicans 
biofilm growth. This inhibition initially appears to function in a cell-density dependent manner, 
but once saturated with cells, further inhibition is not detected. Additionally, when viewed from 
a microscopic level, this inhibition reduces the hyphal morphology of Candida cells, reduces the 
number of Candida cells present, and involves clusters of Alcaligenes growth around the 
Candida cells. In the future we plan to look at other forms of biofilm growth, particularly the 
maturation phase of Candida biofilms. Also of importance is the identification of A. faecalis 
mutants that cannot inhibit Candida to determine the mechanism of this physical interaction. In 
another study implementing the pRL27 Tn5 transposon system, the research group needed to 
screen 10,000 mutants to find the seven mutants that actually had the phenotype they were 
searching for. Further creation of A. faecalis mutants would need to be performed to saturate the 
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